← All companies

BIOA

BioAge Labs, Inc.

BIOA Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.20

+0.42 +3.90%

Key statistics

from XBRL data in SEC filings

Market cap

$498M

Revenue (TTM)

$10.3M

Net income (TTM)

-$89.9M

EPS (TTM)

$-2.40

P/E ratio

—

Dividend yield

—

Free cash flow

-$82.3M

Cash

$242M

Total assets

$398M

Gross margin

—

52-week range

$4.25 – $25.96

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 12, 2026 8-K Results of operations (earnings release) May 8, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 24, 2026 8-K Entered a material agreement; Regulation FD disclosure Jan 22, 2026 8-K Regulation FD disclosure; Other events Jan 20, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement; Unregistered sale of equity Sep 27, 2024

Other filings

4 Jul 1, 2026 144 Jun 30, 2026 144 Jun 29, 2026 4 Jun 12, 2026 4 Jun 12, 2026 4 Jun 12, 2026 4 Jun 12, 2026 4 Jun 12, 2026 4 Jun 12, 2026 SCHEDULE 13G/A May 15, 2026 SCHEDULE 13G/A May 15, 2026 SCHEDULE 13G Apr 27, 2026 4 Apr 24, 2026 ARS Apr 21, 2026 DEFA14A Apr 21, 2026 DEF 14A Apr 21, 2026 4 Apr 3, 2026 144 Apr 1, 2026